EUVIMEDEUVIMED entdecken
Crossref

Lymphopenia associated with survivin and its downstream pathway in COVID-19 serving as a potential route in COVID-19 pathogenesis

Mohammad Saeed Kahrizi, Kamyar Nasiri, Farnoosh Ebrahimzadeh, Amirhossein Fakhre Yaseri, Soroush Ghodratizadeh, Mostafa Gholamrezaei, Alireza Rahat Dahmardeh, Ali Adili, Rosita Amjidifar, Maryam Hemmatzadeh, Mohsen Arabi, Mohammad Reza Maghsoudi und 1 weitere

Advances in Medical Sciences · 2024

DOI: 10.1016/j.advms.2024.03.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Medical Sciences, 2024. Verfasst von Mohammad Saeed Kahrizi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Alborz University of Medical Sciences, Karaj, Alborz, Iran. Hauptthemen laut MEDLINE: Survivin, COVID-19, Apoptosis, Lymphopenia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Alborz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Starting in 2019, coronavirus disease 2019 (COVID-19) caused an epidemic that was growing rapidly and has harmed millions of people globally. It has been demonstrated that survivin regulates lymphocyte survival, a main route involved in COVID-19 pathogenesis. Survivin belongs to the inhibitor of apoptosis protein (IAP) family, and its primary functions comprise regulating mitosis and inhibiting apoptosis. Since lower survivin expression has been shown to increase the sensitivity of lymphocytes to apoptotic induction, we looked into the function of survivin and its corresponding pathways in COVID-19 pathogenesis. MATERIALS AND METHODS: The expression of survivin, X-linked inhibitor of apoptosis protein (XIAP), caspases 3, 7, 9, and poly (ADP-ribose) polymerase (PARP) was evaluated at both mRNA and protein levels in peripheral blood mononuclear cells (PBMCs) derived from healthy donors and patients with severe and moderate COVID-19 by qRT-PCR and Western blotting, respectively. Then, we enforced apoptosis to COVID-19 patient-derived lymphocytes, and the percent was assessed by flow cytometry. RESULTS: Survivin and XIAP were less expressed in PBMCs derived from COVID-19 patients as apoptosis inhibitors than PARP, cleaved-PARP, caspase 9, and cleaved caspases 3 and 7, according to the results of real-time PCR and Western blot analysis. Additionally, according to the flow cytometry results, the down-regulation of survivin served as a potential factor in the lymphocyte depletion observed in patients with COVID-19. CONCLUSION: The role of survivin and its related pathway was first discovered in the development of COVID-19 and may serve as a potential prognostic and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SurvivinCOVID-19ApoptosisLymphopeniaSARS-CoV-2HumansX-Linked Inhibitor of Apoptosis ProteinMaleFemaleLeukocytes, MononuclearMiddle AgedAdultSignal Transduction

Stichwörter der Autor:innen

ApoptosisApoptotic pathwayCOVID-19Survivin

Substanzen

SurvivinBIRC5 protein, humanX-Linked Inhibitor of Apoptosis ProteinXIAP protein, human

Autor:innen und Institutionen

  • Department of Surgery, Alborz University of Medical Sciences, Karaj, Alborz, Iran.
  • Department of Dentistry, Islamic Azad University, Tehran, Iran.
  • Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
  • Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Parasitology and Mycology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Förderung

  • Alborz University of Medical Sciences

Zitieren

APA

Kahrizi, M. S., Nasiri, K., Ebrahimzadeh, F., Yaseri, A. F., Ghodratizadeh, S., Gholamrezaei, M., Rahat Dahmardeh, A., Adili, A., Amjidifar, R., Hemmatzadeh, M., Arabi, M., Maghsoudi, M. R., & Mohammadi, H. (2024). Lymphopenia associated with survivin and its downstream pathway in COVID-19 serving as a potential route in COVID-19 pathogenesis. Advances in Medical Sciences. https://doi.org/10.1016/j.advms.2024.03.006

Vancouver

Kahrizi MS, Nasiri K, Ebrahimzadeh F, Yaseri AF, Ghodratizadeh S, Gholamrezaei M, et al. Lymphopenia associated with survivin and its downstream pathway in COVID-19 serving as a potential route in COVID-19 pathogenesis. Advances in Medical Sciences. 2024. doi:10.1016/j.advms.2024.03.006

BibTeX
@article{Kahrizi2024,
  author = {Kahrizi, Mohammad Saeed and Nasiri, Kamyar and Ebrahimzadeh, Farnoosh and Yaseri, Amirhossein Fakhre and Ghodratizadeh, Soroush and Gholamrezaei, Mostafa and Rahat Dahmardeh, Alireza and Adili, Ali and Amjidifar, Rosita and Hemmatzadeh, Maryam and Arabi, Mohsen and Maghsoudi, Mohammad Reza and Mohammadi, Hamed},
  title = {Lymphopenia associated with survivin and its downstream pathway in COVID-19 serving as a potential route in COVID-19 pathogenesis},
  journal = {Advances in Medical Sciences},
  year = {2024},
  doi = {10.1016/j.advms.2024.03.006}
}
Kostenlos starten →